The firm expects mid-single-digit price erosion in generic drugs and heightened competition for key medications, potentially ...

Healthcare stocks see mixed performance as Dr Lal Pathlabs and Aurobindo Pharma rise over 2% after CLSA upgrades their ...

Brokerage firm Nuvama has highlighted concerns about BPCL's weak refining margin environment and LPG under-recoveries, which are impacting its earnings. Additionally, the high capital expenditure ...

CLSA upgraded the stock to 'hold', citing recent corrections, despite inventory losses and weaker refining margins.

Shares of several companies including BPCL, UltraTech Cement, Dixon Tech, and ​United Spirits, among others, will be in the ...

CLSA analysts downgraded Dr. Reddy's Laboratories shares, trading on both BSE (DRRD:IN) and NYSE (NYSE:RDY), from a Hold to an Underperform rating, adjusting the price target from INR1,140 to INR1,090 ...

Taking a more bearish stance, CLSA has downgraded HUL to an Underperform rating. The brokerage firm also has slashed its ...

There is mild anticipation that as the Snake year slithers in, the local IPO markets will open up, and the STI will hit a new ...

Out of the 43 analysts that now have coverage on HUL, 27 of them have maintained a 'Buy' rating on the stock, while 13 of ...

GEELY AUTO (00175.HK), and SAIC Motor (600104.SH) filed a lawsuit in the EU General Court on Tuesday (21st) to challenge the ...

Donald Trump's return as president, Union Budget, first policy meeting under the Reserve Bank of India's new governor are key ...

India's most valued company, Reliance Industries Ltd (RIL), reported a robust performance in the third quarter of the current ...